Skip to main content
Log in

Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonist

  • Original Papers
  • Published:
Journal of Neural Transmission / General Section JNT Aims and scope Submit manuscript

Summary

The effects of single or repeated doses of antidepressant drugs (imipramine, amitriptyline, citalopram, mianserin) on rat locomotor hyperactivity induced by quinpirole, a dopamine D-2 receptor agonist, was investigated. Single doses of antidepressants do not change the effect of quinpirole, but enhance it when they are administered repeatedly. This enhancement is inhibited by (±)-sulpiride, a dopamine D-2 receptor antagonist. The results obtained indicate that the enhancement of dopaminergically-stimulated hyperactivity induced by repeated doses of antidepressants is mediated by dopamine D-2 receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Arnt J, Hyttel J, Fredericson OverØ K (1984) Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect of dopaminergic and serotonergic function. Pol J Pharmacol Pharm 36: 221–230

    Google Scholar 

  • Borsini T, Pulvirenti L, Samanin R (1985) Evidence of dopamine involvement in the effect of repeated treatment with various antidepressants in behavioural despair test in rats. Eur J Pharmacol 110: 253–256

    Google Scholar 

  • Braun AR, Chase TN (1986) Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors. Eur J Pharmacol 131: 301–306

    Google Scholar 

  • Breese GR, Mueller RA (1985) SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons. Eur J Pharmacol 113: 109–114

    Google Scholar 

  • Cervo L, Samanin R (1987) Evidence that dopamine mechanisms in the nucleus accumbens are selectively involved in the effect of desipramine in the forced swimming test. Neuropharmacology 26: 1469–1472

    Google Scholar 

  • Christensen AV, Fjalland B, Pedersen V, Danneskiold-SamsØe P, Svensen O (1977) Pharmacology of a new phthalane (Lu 10–171), with specific 5-HT uptake inhibiting properties. Eur J Pharmacol 41: 153–162

    Google Scholar 

  • De Ceballos ML, Benech A, De Felipe C, Del Rio J (1985) Prenatal exposure of rats to antidepressants enhances agonist affinity of brain dopamine receptors and dopamine-mediated behaviour. Eur J Pharmacol 116: 257–262

    Google Scholar 

  • Fuller RW, Hemrick-Luecke SK (1985) Decrease in hypothalamic epinephrine concentration and other neurochemical chances produced by quinpirole, a dopamine agonist in rats. J Neural Transm 61: 161–173

    Google Scholar 

  • Hyttel J (1982) Citalopram—pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiat 6: 277–295

    Google Scholar 

  • Jenner P, Marsden CD (1981) Substituted benzamide drugs as selective neuroleptic agents. Neuropharmacology 20: 1285–1293

    Google Scholar 

  • Klimek V, Nielsen M (1987) Chronic treatment with antidepressants decreases the number of3H-SCH 23390 binding sites in rat striatum and the limbic system. Eur J Pharmacol 139: 163–169

    Google Scholar 

  • Klimek V, Nielsen M, Maj J (1985) Repeated treatment with imipramine decreases the number of3H-piflutixol binding sites in the rat striatum. Eur J Pharmacol 109: 131–132

    Google Scholar 

  • Koller W, Herbster G, Anderson D, Wack R, Gordon J (1987) Quinpirole hydrochloride, a potential anti-parkinsonism drug. Neuropharmacology 26: 1031–1036

    Google Scholar 

  • Maj J (1984) Mechanism of action of antidepressant drugs given repeatedly: changes in the responses mediated by noradrenaline (α1) and dopamine receptors. In: Paton W, Michell J, Turner P (eds) Proc. IUPHAR 9th international congress of pharmacology, London, 1984, vol 3, pp 137–143, Macmillan

    Google Scholar 

  • Maj J (1986) Repeated treatment with antidepressant drugs: responses mediated by brain dopamine receptors. In: Hippius H, Klerman GL, Matussek N (eds) New results in depression research. Springer, Berlin Heidelberg New York, pp 90–98

    Google Scholar 

  • Maj J, Papp M, Skuza G, Bigajska K, Zazula M (1989) The influence of repeated treatment with imipramine, (+)- and (−)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists. J Neural Transm 76: 29–38

    Google Scholar 

  • Maj J, Rogóż Z, Skuza G, Sowińska H (1984a) Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine. J Pharm Pharmacol 36: 127–130

    Google Scholar 

  • Maj J, Rogóż Z, Skuza G, Sowińska H (1984b) Repeated treatment with antidepressant drugs increase the behavioural response to apomorphine. J Neural Transm 60: 273–282

    Google Scholar 

  • Maj J, Rogóż Z, Skuza G, Sowinska H (1985) The effects of repeated treatment with antidepressant drugs on the action of D-amphetamine and apomorphine in rats. In: Keleman K, Magyar K, Vizi ES (eds) Neuropharmacology '85. Akademiái Kiadó, Budapest, pp 133–139

    Google Scholar 

  • Maj J, Wędzony K (1985) Repeated treatment with imipramine or amitriptyline increases the locomotor response of rats to (+)-amphetamine given into the nucleus accumbens. J Pharm Pharmacol 37: 362–364

    Google Scholar 

  • Maj J, Wędzony K (1988) The influence of oxaprotiline enantiomers given repeatedly on the behavioural effects of d-amphetamine and dopamine injected into the nucleus accumbens. Eur J Pharmacol 145: 97–103

    Google Scholar 

  • Maj J, Wędzony K, Klimek V (1987) Desipramine given repeatedly enhances behavioural effects of dopamine and d-amphetamine injected into the nucleus accumbens. Eur J Pharmacol 140: 179–185

    Google Scholar 

  • Maj J, Wędzony K, Skuza G (1986) Subsensitivity of presynaptic and supersensitivity of postsynaptic dopaminergic receptors as a result of repeated administration of antidepressant drugs. In: Knoll J, Keleman K (eds) Advances in pharmacological research and practice. Proc, 4th congress of the Hungarian pharmacological society, Budapest 1985, vol 2, pp 47–55. Akademiái Kiadó

    Google Scholar 

  • Martin-Iverson MT, Leclere J-F, Fibiger HC (1983) Cholinergic interactions and the mechanism of action of antidepressants. Eur J Pharmacol 94: 193–201

    Google Scholar 

  • Molloy AG, Waddington JL (1984) Dopaminergic behaviour stereospecifically promoted by the D1 agonist R-SKF 38393 and selectively blocked by the D1 antagonist SCH 23390. Psychopharmacology 82: 409–410

    Google Scholar 

  • Płaźnik A, Kostowski W (1987) The effects of antidepressants and electroconvulsive shock on the functioning of the mesolimbic dopaminergic system: a behavioral study. Eur J Pharmacol 135: 389–396

    Google Scholar 

  • van Riezen H, Pinder RM, Nicolson VJ, Hobbelen P, Zayed I, van der Veen F (1981) Mianserin: a really different antidepressant. In: Goldberg ME (ed) Pharmacological and biochemical properties of drug substances. American Pharmaceutical Association, Washington, pp 1–38

    Google Scholar 

  • Seeman P (1980) Brain dopamine receptors. Pharmacol Rev 32: 229–313

    Google Scholar 

  • Sharp T, Zetterström T, Collin A-K, Ungerstedt U (1987) The D-2 agonist quinpirole releases striatal dopamine in vivo. Eur J Pharmacol 142: 187–188

    Google Scholar 

  • Skuza G, Rogóż Z, żak J (1989) Effect of antidepressant drugs and different receptor antagonists on the grooming induced by the dopamine D-1 agonist SKF 38393. Pol J Pharmacol Pharm 41: in press

  • Śmiałowski A, Maj J (1985) Repeated treatment with imipramine potentiates the locomotor effect of apomorphine administered into hippocampus. Psychopharmacology 86: 468–471

    Google Scholar 

  • Spyraki C, Fibiger HC (1981) Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. Eur J Pharmacol 74: 195–206

    Google Scholar 

  • Starr BS, Starr MS (1986) Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implication for the roles of D1 and D2 receptors. Neuropharmacology 5: 455–463

    Google Scholar 

  • Stoof JC, Kebabian JW (1984) Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci 35: 2281–2296

    Google Scholar 

  • Tsuruta K, Frey EA, Grewe CW, Cote TE, Eskay RL, Kebabian JW (1981) Evidence that LY 141865 specifically stimulates the D-2 dopamine receptors. Nature 292: 463–465

    Google Scholar 

  • Walters JR, Bergstrom DA, Carlson JH, Chase TN, Braun AR (1987) D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. Science 236: 719–722

    Google Scholar 

  • Willner F (1983) Dopamine and depression: a review of recent evidence. III. The effect of antidepressant treatment. Brain Res Rev 6: 237–246

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maj, J., Rogóż, Z., Skuza, G. et al. Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonist. J. Neural Transmission 78, 1–8 (1989). https://doi.org/10.1007/BF01247108

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01247108

Keywords

Navigation